Capital Analysts LLC boosted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 8.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 17,258 shares of the conglomerate's stock after acquiring an additional 1,273 shares during the quarter. Capital Analysts LLC's holdings in Danaher were worth $3,961,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. Kentucky Retirement Systems Insurance Trust Fund boosted its stake in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after acquiring an additional 2,202 shares in the last quarter. ORG Partners LLC boosted its position in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after purchasing an additional 2,559 shares during the period. Generate Investment Management Ltd purchased a new position in Danaher in the 4th quarter worth about $8,044,000. Compass Capital Management Inc. raised its holdings in Danaher by 4.8% during the 4th quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after buying an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC lifted its stake in Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock valued at $1,301,000 after buying an additional 1,698 shares in the last quarter. Institutional investors own 79.05% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on DHR. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. Raymond James reissued a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. JPMorgan Chase & Co. decreased their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Finally, Guggenheim reiterated a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $264.40.
View Our Latest Stock Report on DHR
Danaher Stock Performance
Shares of NYSE:DHR traded down $1.76 during trading on Thursday, reaching $197.58. 1,935,916 shares of the stock were exchanged, compared to its average volume of 3,354,521. The firm has a market cap of $141.40 billion, a PE ratio of 37.40, a PEG ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The stock has a 50-day moving average price of $200.30 and a 200-day moving average price of $223.12.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Research analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.
Danaher Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, April 25th. Investors of record on Friday, March 28th were given a dividend of $0.32 per share. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher's dividend payout ratio (DPR) is currently 24.85%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
